Floatz logo

Calaspargase Pegol

Acute Leukemia of Ambiguous Lineage

SWOG Cancer Research Networkprotein_peptidePhase 2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
73/ 100

Competitive context

45 Active assets in the Acute Leukemia of Ambiguous Lineage cohort.

Asset / SponsorPhaseRating
L-Ofloxacin
Children's Oncology Group
Phase 3BB
Cyclophosphamide
SWOG Cancer Research Network
Phase 2BB
Cytosin-Arabinosid
SWOG Cancer Research Network
Phase 2B
METHOTREXATE
SWOG Cancer Research Network
Phase 2B
VINCRISTINE SULFATE
Children's Oncology Group
Phase 2B

View all 50 →

Same molecule, other indications

Calaspargase Pegol is also rated in:

lymphoblastic lymphomaDormant
BB
Indicative ·
70 / 100
View asset →
acute lymphoblastic leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, Non-Small-Cell Lung (NSCLC)Dormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →